Pindolol NDC 76385-132

NDC codes

FDA NDC Directory

Product NDC (as listed)76385-132Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76385-0132Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76385-132-01	76385013201	100 TABLET in 1 BOTTLE, PLASTIC (76385-132-01)Marketed from Feb 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pindolol
Generic name (nonproprietary): pindolol
Active ingredients: Pindolol — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Unichem Pharmaceuticals (USA), Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211712
Marketing start: Feb 1, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 76385-132_9b26764d-3ed0-4cb8-8740-355800dc62e1SPL ID 9b26764d-3ed0-4cb8-8740-355800dc62e1SPL set ID f529ff35-f82b-4a3a-96b4-096bfc8e81b5RxCUI 198104, 198105UNII BJ4HF6IU1DUPC 0376385132019, 0376385131012
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476385013201 followed by a unit qualifier and the quantity

Package 76385-0132-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Pindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211712

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211712
Product	Strength	Form · route	Labeler	Product NDC
Pindolol	Pindolol 5 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	76385-131
Pindolol	Pindolol 5 mg/1	TabletOral	Bryant Ranch Prepack	63629-4828
Pindolol	Pindolol 5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-100
Pindolol	Pindolol 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-099